Page 24 - Tim Boreham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This story features AFTERPAY LIMITED, and other companies. For more info SHARE ANALYSIS: APT The New Criterion's Tim Boreham discusses whether it's not too late to jump on the BNPL gravy train Should investors succumb to the BNPL FOMO? By Tim Boreham, Editor, The New Criterion As with the coronavirus, the buy now pay later (BNPL) sector was expected to have fizzled out by now. Instead, it’s stepped up another level in terms of revenue usage trends and valuations. Among investors, Fear of Missing Out (FOMO) is rife as the BNPL contagion continues to displace the role of credit cards in pers...

Something For Nothing This story features Universal Biosensors, and other companies. For more info SHARE ANALYSIS: UBI It is indeed possible to get something from nothing. Four small-caps appear to be defying the norms of capitalism. By Tim Boreham These companies are trading at close to cash backing, but are the discounts justified? “Something for nothing” is a powerful notion, implying free provision of valuable goods and services in contravention of the natural rules of capitalism. But in small-cap land it is indeed possible to get something for nothing – or almost nothing – in the...

The First Connection This story features 1st Group Ltd, and other companies. For more info SHARE ANALYSIS: 1ST Future prospects of the health booking platform – 1st Group – with some new opportunities on the horizon By Tim Boreham How a founder’s ASX-listed healthcare platform saved his own life Health platform founder Klaus Bartosch offers an unusually personal and powerful endorsement of his own company: it literally saved his life. Eight years ago Bartosch created 1st Group ((1ST)) to facilitate online medical appointments, given most of them were (and still are) made over the phone...